Defining Bedaquiline Susceptibility, Resistance, Cross-Resistance and Associated Genetic Determinants: A Retrospective Cohort Study

BACKGROUND: Bedaquiline (BDQ) is a novel agent approved for use in combination treatment of multi-drug resistant tuberculosis (MDR-TB). We sought to determine BDQ epidemiological cut-off values (ECVs), define and assess interpretive criteria against putative resistance associated variants (RAVs), mi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ismail, Nazir A., Omar, Shaheed V., Joseph, Lavania, Govender, Netricia, Blows, Linsay, Ismail, Farzana, Koornhof, Hendrik, Dreyer, Andries W., Kaniga, Koné, Ndjeka, Norbert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835552/
https://www.ncbi.nlm.nih.gov/pubmed/29337135
http://dx.doi.org/10.1016/j.ebiom.2018.01.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835552/
https://www.ncbi.nlm.nih.gov/pubmed/29337135
http://dx.doi.org/10.1016/j.ebiom.2018.01.005

Ejemplares similares